TXMD stock pitch - 2024-05-23

Added to YB: 2024-05-23

Pitch date: 2024-05-23

TherapeuticsMD, Inc.

current return

Author Info

No bio for this author

Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium

Company Info

TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States and internationally.

Market Cap

$25.7M

Pitch Price

$2.08

Price Target

N/A

Dividend

N/A

EV/EBITDA

-19.46

P/E

-74.34

EV/Sales

6.75

Sector

Pharmaceuticals

A summary for this pitch has not been created yet.